Normal endometrial cells in cervical cytology: Systematic review of prevalence and relation to significant endometrial pathology

Journal of Medical Screening

Volumn 15, Issue 4, 2008, Pages 188-198

  Canfell, Karen ^a   Yoon, Jung Kang ^a,b   Clements, Mark ^d   Moa, Aye Myat ^b   Beral, Valerie ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Epidemiology Unit   (Australia)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENDOMETRIUM CARCINOMA; ENDOMETRIUM CELL; ENDOMETRIUM HYPERPLASIA; FOLLOW UP; GROUPS BY AGE; HUMAN; POSTMENOPAUSE; PREVALENCE; REVIEW; SENSITIVITY ANALYSIS; SMEAR; SYSTEMATIC REVIEW; TECHNOLOGY; UTERINE CERVIX CYTOLOGY; ARTICLE; BIOPSY; CYTOLOGY; ENDOMETRIUM; ENDOMETRIUM TUMOR; FEMALE; MENSTRUAL CYCLE; PATHOLOGY; PHYSIOLOGY; RISK FACTOR; UTERUS DISEASE; VAGINA SMEAR;

ORAL CONTRACEPTIVE AGENT;

BIOPSY; CONTRACEPTIVES, ORAL; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; FOLLOW-UP STUDIES; HUMANS; MENSTRUAL CYCLE; PREVALENCE; RISK FACTORS; UTERINE DISEASES; VAGINAL SMEARS;

EID: 62749098732     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1258/jms.2008.008069     Document Type: Review

References (47)

1. Bray F, dos SSI, Moller H, et al. Endometrial cancer incidence trends in Europe: underlying determinants and prospects for prevention. Cancer Epidemiol Biomarkers Prev 2005;14:1132-1142
2. Reeves GK, Pirie K, Beral V, et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. Br Med J 2007;335:1134 (Pubitemid 350247286)
3. Beral V, Bull D, Reeves G. Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet 2005;365:1543-1551 (Pubitemid 40615403)
4. Fadare O, Ghofrani M, Chacho MS, et al. The significance of benign endometrial cells in cervicovaginal smears. Adv Anat Pathol 2005;12:274-287 (Pubitemid 41463809)
5. Mitchell H, Giles G, Medley G. Accuracy and survival benefit of cytological prediction of endometrial carcinoma on routine cervical smears. Int J Gynecol Pathol 1993;12:34-40 (Pubitemid 23013909)
6. Fukuda K, Mori M, Uchiyama M, et al. Preoperative cervical cytology in endometrial carcinoma and its clinicopathologic relevance. Gynecol Oncol 1999;72:273-277 (Pubitemid 29118181)
7. Johnson EJ, Patnick J. Achievable standards, benchmarks for reporting, and criteria for evaluating cervical cytopathology. Second edition including revised performance indicators. Cytopathology 2000;11:212-241
8. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-2119
9. National Cervical Screening Programme (NZ). Bethesda 2001: New Zealand Modified. Codes, Descriptors and Assessment of Sample Adequacy for Cytology Laboratories. Wellington, New Zealand: Ministry of Health; 2005
10. National Health and Medical Research Council. Screening to Prevent Cervical Cancer: Guidelines for the Management of Asymptomatic Women with Screen Detected Abnormalities. See http://www.nhmrc.gov.au/publications/synopses/ wh39syn.htm (last checked 15 February 2006)
11. Liu W, Barrow MJ, Spitler MF, et al. Normal exfoliation of endometrial cells in premenopausal women. Acta Cytol 1963;7:211-214
12. Ng AB. The cellular detection of endometrial carcinoma and its precursors. Gynecol Oncol 1974;2:162-179
13. Ng AB, Reagan JW, Hawliczek S, et al. Significance of endometrial cells in the detection of endometrial carcinoma and its precursors. Acta Cytol 1974;18:356-361
14. Vooijs GP, van der GY, Vooijs MA. The presence of endometrial cells in cervical smears in relation to the day of the menstrual cycle and the method of contraception. Acta Cytol 1987;31:427-433 (Pubitemid 17124201)
15. Chang BS, Pinkus GS, Cibas ES. Exfoliated endometrial cell clusters in cervical cytologic preparations are derived from endometrial stroma and glands. Am J Clin Pathol 2006;125:77-81 (Pubitemid 43089728)
16. Guruwadayarhalli B, Jones SE, Srinivasan V. Hysteroscopy in the diagnosis of postmenopausal bleeding. Menopause Int 2007;13:132-134
17. Williams SC, Lopez C, Yoong A, et al. Developing a robust and efficient pathway for the referral and investigation of women with post-menopausal bleeding using a cut-off of < or =4 mm for normal thickness. Br J Radiol 2007;80:719-723 (Pubitemid 350033110)
18. Timmermans A, Opmeer BC, Veersema S, et al. Patients' preferences in the evaluation of postmenopausal bleeding. BJOG 2007;114:1146-1149 (Pubitemid 47247027)
19. Paschopoulos M, Polyzos NP, Lavasidis LG, et al. Safety issues of hysteroscopic surgery. Ann N Y Acad Sci 2006;1092:229-234 (Pubitemid 47092340)
20. Nappi C, Di Spiezio SA, Greco E, et al. Prevention of adhesions in gynaecological endoscopy. Hum Reprod Update 2007;13:379-394 (Pubitemid 47062830)
21. Stamatellos I, Koutsougeras G, Karamanidis D, et al. Results after hysteroscopic management of premenopausal patients with dysfunctional uterine bleeding or intrauterine lesions. Clin Exp Obstet Gynecol 2007;34:35-38 (Pubitemid 46648418)
22. Shveiky D, Rojansky N, Revel A, et al. Complications of hysteroscopic surgery: "Beyond the learning curve". J Minim Invasive Gynecol 2007;14:218-222
23. Dobosz J. Testing Positive for Growth. MA, USA: Cytyc Corporation, 2008. See http://www.forbes.com/2005/03/30/cz-jd-0330gurusow-inl.html (accessed May 2008)
24. Cherkis RC, Patten Jr.SF, Andrews TJ, et al. Significance of normal endometrial cells detected by cervical cytology. Obstet Gynecol 1988;71:242-244 (Pubitemid 18053488)
25. Yancey M, Magelssen D, Demaurez A, et al. Classification of endometrial cells on cervical cytology. Obstet Gynecol 1990;76:1000-1005
26. Gomez-Fernandez CR, Ganjei-Azar P, Capote-Dishaw J, et al. Reporting normal endometrial cells in Pap smears: an outcome appraisal. Gynecol Oncol 1999;74:381-384 (Pubitemid 29439877)
27. Gray JA, Nguyen GK. Cytologic detection of endometrial pathology by Pap smears. Diagn Cytopathol 1999;20:181-182 (Pubitemid 29111251)
28. Chang A, Sandweiss L, Bose S. Cytologically benign endometrial cells in the papanicolaou smears of postmenopausal women. Gynecol Oncol 2001;80:37-43 (Pubitemid 32062086)
29. Ashfaq R, Sharma S, Dulley T, et al. Clinical relevance of benign endometrial cells in postmenopausal women. Diagn Cytopathol 2001;25:235-238 (Pubitemid 32906104)
30. Montz FJ. Significance of 'normal' endometrial cells in cervical cytology from asymptomatic postmenopausal women receiving hormone replacement therapy. Gynecol Oncol 2001;81:33-39
31. Sarode VR, Rader AE, Rose PG, et al. Significance of cytologically normal endometrial cells in cervical smears from postmenopausal women. Acta Cytol 2001;45:153-156 (Pubitemid 32234897)
32. Wu HH, Schuetz III MJ, Cramer H. Significance of benign endometrial cells in Pap smears from postmenopausal women. J Reprod Med 2001;46:795-798 (Pubitemid 32924252)
33. Mount SL, Wegner EK, Eltabbakh GH, et al. Significant increase of benign endometrial cells on Papanicolaou smears in women using hormone replacement therapy. Obstet Gynecol 2002;100:445-450 (Pubitemid 35246129)
34. Brogi E, Tambouret R, Bell DA. Classification of benign endometrial glandular cells in cervical smears from postmenopausal women. Cancer 2002;96:60-66 (Pubitemid 34438645)
35. Cai N, Spitzer M, Wasserman PG. Endometrial cells in pap smears of postmenopausal women: cytohistologic correlation. J Low Genit Tract Dis 2003;7:250-253 (Pubitemid 37336595)
36. Browne TJ, Genest DR, Cibas ES. The clinical significance of benign-appearing endometrial cells on a Papanicolaou test in women 40 years or older. Am J Clin Pathol 2005;124:834-837 (Pubitemid 41740182)
37. Simsir A, Carter W, Elgert P, et al. Reporting endometrial cells in women 40 years and older: assessing the clinical usefulness of Bethesda 2001. Am J Clin Pathol 2005;123:571-575 (Pubitemid 40418552)
38. Thrall MJ, Kjeldahl KS, Savik K, et al. Significance of benign endometrial cells in papanicolaou tests from women aged >or = 40 years. Cancer 2005;105:207-216 (Pubitemid 41177000)
39. Bean SM, Connolly K, Roberson J, et al. Incidence and clinical significance of morphologically benign-appearing endometrial cells in patients age 40 years or older: the impact of the 2001 Bethesda System. Cancer 2006;108:39-44
40. Siebers AG, Verbeek AL, Massuger LF, et al. Normal appearing endometrial cells in cervical smears of asymptomatic postmenopausal women have predictive value for significant endometrial pathology. Int J Gynecol Cancer 2006;16:1069-1074 (Pubitemid 43886728)
41. Aslan DL, Crapanzano JP, Harshan M, et al. The Bethesda System 2001 recommendation for reporting of benign appearing endometrial cells in Pap tests of women age 40 years and older leads to unwarranted surveillance when followed without clinical qualifiers. Gynecol Oncol 2007;107:86-93
42. Beal HN, Stone J, Beckmann MJ, et al. Endometrial cells identified in cervical cytology in women > or = 40 years of age: criteria for appropriate endometrial evaluation. Am J Obstet Gynecol 2007;196:568-575 (Pubitemid 46836614)
43. Kapali M, Agaram NP, Dabbs D, et al. Routine endometrial sampling of asymptomatic premenopausal women shedding normal endometrial cells in Papanicolaou tests is not cost effective. Cancer 2007;111:26-33 (Pubitemid 46281081)
44. Moroney JW, Zahn CM, Heaton RB, et al. Normal endometrial cells in liquid-based cervical cytology specimens in women aged 40 or older. Gynecol Oncol 2007;105:672-676 (Pubitemid 46738578)
45. Whiting P, Rutjes AW, Reitsma JB, et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003;3:25 (Pubitemid 38789561)
46. d'Arailh AS, Michy T, Pioud R, et al. [Uterine abnormalities in non-menopausal women received tamoxifen for breast cancer adjuvant therapy.]. Gynecol Obstet Fertil 2007;35:1215-1219
47. Hickey M. Bleeding with menopausal hormone therapy: physiological or pathological? Menopause Int 2007;13:188-190